WS-16 - SI Joint Fusion

Friday, November 22, 2024

1:30 PM - 3:30 PM PT

Location: Milano 4

Earn: 2 CME Credits

Lead(s)

Maged Guirguis, MD

System chairman
Ochsner Health

Faculty(s)

Aaron Calodney, MD, FASA,FIPP, ABIPP (he/him/his)

Director of Clinical Research
Precision Spine Care
Tyler, Texas, United States
AG

Amitabh Gulati, MD (he/him/his)

Associate attending
MSKCC
New York, New York, United States

Associate Faculty(s)

Chris Mallard, MD

Assistant Professor of Anesthesia, Program Director Pain Medicine Fellowship, Medical Director Interventional Pain Associates
University of Kentucky
Lexington, Kentucky, United States
Alexander Escobar, MD

Division Chief Pain Medicine and Program Director
University of Toledo

Disclosure(s):

Maged Guirguis, MD: Abbott: Consulting/Advisory Board (Terminated, February 1, 2024); AVANOS: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); averitas: Consulting/Advisory Board (Ongoing); Boston Scientific: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Consulting/Advisory Board (Terminated, January 4, 2024), Funded Research (Institution) (Terminated, January 4, 2024); Pacira: Consulting/Advisory Board (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Saluda: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Terminated, November 30, 2023)

Aaron Calodney, MD, FASA,FIPP, ABIPP: Boston Scientific: Funded Research (Institution) (Ongoing); Companion Spine: Consulting/Advisory Board (Ongoing); DiscGenics: Funded Research (Institution) (Ongoing); Medtronic: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Nevro Corp: Funded Research (Institution) (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); ReGelTec: Funded Research (Institution) (Ongoing); Relievant: Funded Research (Institution) (Ongoing), Speakers Bureau (Ongoing); Saluda: Funded Research (Institution) (Ongoing); Saol Therapeutics: Funded Research (Institution) (Ongoing); Spine Biopharma: Funded Research (Institution) (Ongoing); Stryker: Funded Research (Institution) (Ongoing); Vertos: Consulting/Advisory Board (Ongoing), Funded Research (Institution) (Ongoing); Vivex: Funded Research (Institution) (Ongoing)

Amitabh Gulati, MD: AIS healthcare: Consulting/Advisory Board (Ongoing); Medtronic: Consulting/Advisory Board (Ongoing); Nalu Medical: Consulting/Advisory Board (Ongoing); Neurovasis: Consulting/Advisory Board (Ongoing); SPR Therapeutics: Consulting/Advisory Board (Ongoing); Tersera: Consulting/Advisory Board (Ongoing)

Chris Mallard, MD: Medtronic: Funded Research (Institution) (Ongoing); Zavation: Consulting/Advisory Board (Terminated, June 3, 2022)

Alexander Escobar, MD: Medtronic: Consulting/Advisory Board (Ongoing), Honoraria/Expense (Ongoing); Nevro Corp: Consulting/Advisory Board (Ongoing), Honoraria/Expense (Ongoing), Speakers Bureau (Ongoing); PainTeq: Consulting/Advisory Board (Ongoing); Vertos: Consulting/Advisory Board (Ongoing), Honoraria/Expense (Ongoing), Speakers Bureau (Ongoing)

Learning Objectives:

Review patient selection criteria and preoperative imaging
Recognize the anatomy of SI joint and its variability among patients
Differentiate among different approaches to access the joint utilizing guided imaging
Avoid most complications and manage these complications, if they occur